MalarVx
Paul Harris, Ph.D., Vice President of Product Development, shares the vision to create a safe, affordable, highly effective malaria vaccine. Paul is one of the most successful cell-culture and molecular biology engineers in the biotechnology industry has developed successful medical device and diagnostic systems, including cell/tissue culture automated systems for many companies. He holds a Ph.D. in Molecular Biology and Biochemistry and has held positions as VP and Chief Science Officer at Response Biomedical Corporation, Director of R&D at STC Technologies, Director of Systems Engineering and Manufacturing Operations at Microprobe, Vice President of Engineering at Cellpro lnc., and Director of Systems Development at Sanofi Diagnostics Pasteur. Dr. Harris has 24 issued US patents.
This person is not in any offices
MalarVx
MalarVx is a bio-pharmaceutical company located in the Center for Infectious Disease Research facility in Seattle, Washington. They founded MalarVx to address the myriad challenges of creating a safe, affordable, effective malaria vaccine using innovative new technologies discovered through research.